Testosterone Therapy in Men with Hypogonadism: An Endocrine Society

Keyphrases

• Prostate Cancer 100%
• Testosterone Replacement Therapy 100%
• Hypogonadism 100%
• Endocrine Society 100%
• Adverse Effects 66%
• Hematocrit 66%
• Androgen Deficiency 66%
• Treatment Burden 33%
• Prostate 33%
• African American 33%
• Myocardial Infarction 33%
• Heart Failure 33%
• Diagnostic Test 33%
• Breast Cancer 33%
• Nodule 33%
• Testosterone 33%
• Pharmacokinetics 33%
• Patient Preference 33%
• Treatment Monitoring 33%
• Clinical Practice Guidelines 33%
• Obstructive Sleep Apnea 33%
• First Year 33%
• Prostate-specific Antigen Level 33%
• Prostate Cancer Risk 33%
• First-degree Relatives 33%
• African Men 33%
• Prostate-specific Antigen 33%
• Lower Urinary Tract Symptoms 33%
• Treatment Costs 33%
• Evidence-based Guidelines 33%
• Group Meetings 33%
• Diagnostic Evaluation 33%
• Potential Gains 33%
• Potential Risk 33%
• Conference Calls 33%
• Evaluation Approach 33%
• Induration 33%
• Best Available Evidence 33%
• Content Expert 33%
• Low Serum 33%
• Lower Limit of Normal 33%
• Equilibrium Dialysis 33%
• One-group 33%
• Evaluation Assessment 33%
• Consensus Process 33%
• Grading of Recommendations 33%
• Secondary Sexual Traits 33%
• Assessment Approach 33%
• Assessment Development 33%
• Development Approach 33%
• Recommendation Approach 33%
• Sex Hormone-binding Globulin 33%
• Thrombophilia 33%
• Strength of Recommendations 33%
• Consensus Development 33%
• Methodologists 33%
• Email Communication 33%
• Medical Contents 33%
• Androgen Deficiency Syndrome 33%

Medicine and Dentistry

• Prostate Cancer 100%
• Hypogonadism 100%
• Androgen Therapy 100%
• Androgen Deficiency 75%
• Clinician 50%
• Systematic Review 50%
• Prostate Specific Antigen 50%
• Hematocrit 50%
• Adverse Effect 50%
• Decision Making 25%
• Health Care Cost 25%
• Myocardial Infarction 25%
• Apoplexy 25%
• Breast Cancer 25%
• Cancer Risk 25%
• Congestive Heart Failure 25%
• Patient Preference 25%
• Pharmacokinetics 25%
• Obstructive Sleep Apnea 25%
• Physical Disease by Body Function 25%
• Lower Urinary Tract Symptom 25%
• Sex Hormone Binding Globulin 25%
• Thrombophilia 25%
• Methodologist 25%
• Facilitated Communication 25%
• Diagnostic Test 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Hypogonadism 100%
• Androgen Deficiency 75%
• Prostate Specific Antigen 50%
• Heart Infarction 25%
• Syndrome 25%
• Breast Cancer 25%
• Sleep Disordered Breathing 25%
• Physical Disease by Body Function 25%
• Congestive Heart Failure 25%
• Cerebrovascular Accident 25%
• Lower Urinary Tract Symptom 25%
• Thrombophilia 25%
• Sex Hormone Binding Globulin 25%
• Pharmacokinetics 25%